MCID: MTC028
MIFTS: 30

Mitochondrial Cardiomyopathy malady

Categories: Genetic diseases (common), Cardiovascular diseases

Aliases & Classifications for Mitochondrial Cardiomyopathy

About this section

Aliases & Descriptions for Mitochondrial Cardiomyopathy:

Name: Mitochondrial Cardiomyopathy 22 24 65
 
Cardiomyopathy, Maternally Transmitted 22

Classifications:



External Ids:

UMLS65 C3532239

Summaries for Mitochondrial Cardiomyopathy

About this section
MalaCards based summary: Mitochondrial Cardiomyopathy, also known as cardiomyopathy, maternally transmitted, is related to 3-methylglutaconic aciduria, type i and mitochondrial complex iv deficiency. An important gene associated with Mitochondrial Cardiomyopathy is MT-TL1 (Mitochondrially Encoded TRNA Leucine 1 (UUA/G)), and among its related pathways is tRNA Aminoacylation. Affiliated tissues include heart, skeletal muscle and brain.

Related Diseases for Mitochondrial Cardiomyopathy

About this section

Graphical network of the top 20 diseases related to Mitochondrial Cardiomyopathy:



Diseases related to mitochondrial cardiomyopathy

Symptoms for Mitochondrial Cardiomyopathy

About this section

Drugs & Therapeutics for Mitochondrial Cardiomyopathy

About this section

Drugs for Mitochondrial Cardiomyopathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 37)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Cysteamineapproved, investigationalPhase 2, Phase 32360-23-16058
Synonyms:
(2-Mercaptoethyl)amine
(Mercaptoethyl)ammonium toluene-p-sulphonate
.beta.-Mercaptoethylamine
1-Amino-2-mercaptoethylamine
139720-70-0
156-57-0 (hydrochloride)
16904-32-8 (di-hydrochloride)
2-AMINO-ETHANETHIOL
2-AMINO-ethanethiol
2-Amino-1-ethanethiol
2-Aminoethanethiol
2-Aminoethyl mercaptan
2-Mercaptoethanamine
2-Mercaptoethylamine
2-Mercaptoethylamine, polymer-bound
27761-19-9 (tartrate (1:1))
2DFDA1F8-7010-4225-8280-AB1C4C43F546
30070_FLUKA
30070_SIGMA
3037-04-5
3037-04-5 (tosylate)
42954-15-4 (hydrobromide)
60-23-1
60-23-1 (Parent)
641022_ALDRICH
93965-19-6 (maleate (1:1))
A0648
AC1L1LPL
AC1Q54NL
AKOS003793343
Aminoethyl mercaptan
Becaptan
C-9500
C01678
C2H7NS
CASH
CCRIS 3083
CHEBI:17141
CHEMBL602
CID6058
CYSTEAMINE
Cisteamina
Cisteamina [Italian]
Cystagon
Cystaran
Cystavision
Cysteamide
Cysteamin
Cysteamine
Cysteamine (USAN)
Cysteamine Bitartrate
Cysteamine Hydrochloride
Cysteamine [USAN:BAN]
Cysteamine bitartate
Cysteamine hydrochloride
Cysteaminium
Cysteinamine
D03634
DB00847
 
Decarboxycysteine
DivK1c_006750
EINECS 200-463-0
EINECS 221-235-7
Ethanethiolamine
HSDB 7353
KBio1_001694
KBio2_002235
KBio2_004803
KBio2_007371
KBioSS_002235
L 1573
L-1573
LS-65761
Lambraten
Lambratene
Lopac-M-6500
M9768_ALDRICH
M9768_SIGMA
MEA
MEA (mercaptan)
Mecramine
Mercamin
Mercamine
Mercaptamin
Mercaptamina
Mercaptamina [INN-Spanish]
Mercaptamine
Mercaptamine (INN)
Mercaptaminum
Mercaptaminum [INN-Latin]
Mercaptoethylamine
Merkamin
MolPort-001-662-635
NCGC00015691-01
NCGC00015691-04
NCGC00162236-01
NCI60_002000
NSC 647528
NSC647528
Riacon
STK315355
SpecPlus_000654
Spectrum_001755
Thioethanolamine
UNII-5UX2SD1KE2
WR 347
b-Aminoethanethiol
b-Aminoethylthiol
b-Mercaptoethylamine
beta-Aminoethanethiol
beta-Aminoethylthiol
beta-MEA
beta-Mercaptoethylamine
bmse000388
cysteamine bitartrate
nchembio.315-comp1
nchembio.316-comp1
β-MEA
β-aminoethylthiol
2
IronapprovedPhase 1, Phase 210217439-89-623925
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
ATW 230
ATW 432
Ancor B
Ancor en 80/150
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
C00023
C3518_SIAL
C3518_SIGMA
CCRIS 1580
CHEBI:18248
CID23925
Carbonyl iron
Copy Powder CS 105-175
D007501
DB01592
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Dexiron
Diseases (animal), iron overload
Diseases, iron overload
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
Ed-In-Sol
 
Eisen
F 60 (metal)
FE
FT 3 (element)
Fe
Fe-40
Fe1+
Feraheme
Feronate
Ferretts
Ferrlecit
Ferro-Caps
Ferro-Time
Ferrousal
Ferrovac E
Ferrum
GS 6
HF 2 (element)
HL (iron)
HQ (metal)
HS (iron)
HS 4849
HSDB 604
Hemocyte
Hierro
Hoeganaes ATW 230
Hoeganaes EH
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Infufer
Iron
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron monocation
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(III) nitrate solution
Iron, elemental
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
LOHA
LS-3196
MolPort-003-925-001
NC 100
PZh-1M3
PZh-2
PZh1M1
PZh2M
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
Remko
SUY-B 2
Siderol
UNII-E1UOL152H7
Venofer
Vitedyn-Slo
Yieronia
fer
ferrous ascorbate
ferrous fumarate
ferrous gluconate
ferrous glycine sulfate
ferrous iron
ferrous succinate
ferrous sulfate
hierro
3
Epoetin alfaapprovedPhase 2626113427-24-0
Synonyms:
Epogen
 
Erythropoietin precursor
Procrit
4
Resveratrolexperimental, investigationalPhase 1, Phase 2105501-36-0, 955365-80-724856436, 445154
Synonyms:
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol
(E)-5-(p-Hydroxystyryl)resorcinol
(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol
(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol
(E)-resveratrol
 
3,4',5-Stilbenetriol
3,4',5-Trihydroxystilbene
3,4',5-trihydroxy-stilbene
MK-1775
trans-3,4',5 - Trihydroxystilbene
trans-3,4',5-trihydroxystilbene
trans-Resveratrol
5Antirheumatic AgentsPhase 1, Phase 28496
6AntioxidantsPhase 1, Phase 22442
7Peripheral Nervous System AgentsPhase 1, Phase 218510
8Platelet Aggregation InhibitorsPhase 1, Phase 21935
9Protective AgentsPhase 1, Phase 25651
10Antineoplastic Agents, PhytogenicPhase 1, Phase 24294
11HematinicsPhase 21121
12Anti-Inflammatory Agents, Non-SteroidalPhase 1, Phase 23549
13Iron Chelating AgentsPhase 1, Phase 2178
14Chelating AgentsPhase 1, Phase 2667
15Trace ElementsPhase 1, Phase 23900
16MicronutrientsPhase 1, Phase 23901
17AnalgesicsPhase 1, Phase 29358
18Anti-Inflammatory AgentsPhase 1, Phase 28478
19Analgesics, Non-NarcoticPhase 1, Phase 25184
20
Heparinapproved, investigational7199005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin
21
Vitamin Eapproved, nutraceutical37159-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-alpha-tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'r)-alpha-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-alpha-tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitamin e
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
d-alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
22
Glycerolexperimental19156-81-5753
Synonyms:
1,2,3-Trihydroxypropane
Bulbold
Cristal
E 422
Emery 916
Glyceol Opthalgan
Glycerin
Glycerine
Glyceritol
Glycerol
 
Glycyl alcohol
Glyrol
Glysanin
IFP
Incorporation factor
Mackstat H 66
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Trihydroxypropane
Tryhydroxypropane
23Insulin, Globin Zinc4278
24insulin4278
25Hypolipidemic Agents2228
26ACIPIMOX15
27Antimetabolites9454
28Hormones11748
29calcium heparin719
30Pharmaceutical Solutions7004
31Tocopherols376
32Vitamins3857
33Tocotrienols372
34carnitineNutraceutical146
35pyruvateNutraceutical30
36TocopherolNutraceutical376
37TocotrienolNutraceutical372

Interventional clinical trials:

(show all 23)
idNameStatusNCT IDPhase
1Open-Label, Dose-Escalating Study to Assess Safety, Tolerability, Efficacy, PK and PD of RP103 in Children With Inherited Mitochondrial DiseaseEnrolling by invitationNCT02023866Phase 2, Phase 3
2Iron-Chelating Therapy and Friedreich AtaxiaCompletedNCT00224640Phase 1, Phase 2
3A Study of Resveratrol as Treatment for Friedreich AtaxiaCompletedNCT01339884Phase 1, Phase 2
4Efficacy of Epoetin Alfa in Patients With Friedreich's AtaxiaCompletedNCT00631202Phase 2
5Efficacy Study of Epoetin Alfa in Friedreich AtaxiaCompletedNCT01493973Phase 2
6High Protein Diet in Patients With Long-chain Fatty Acid Oxidation DisordersCompletedNCT01494051Phase 1, Phase 2
7A Long-Term Extension Study of RP103-MITO-001 to Assess RP103 in Children With Inherited Mitochondrial DiseaseEnrolling by invitationNCT02473445Phase 2
8Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial FunctionCompletedNCT00943059
9Nutritional Assessment in Mitochondrial CytopathyCompletedNCT02375438
10Effect Of The System In The Enriched Fat Metabolism Of The Child Reached Mitochondrial CytopathyCompletedNCT02385565
11Exercise Training in Barth SyndromeCompletedNCT01194141
12Effects of Parenteral L-carnitine Supplementation in Premature NeonatesCompletedNCT00841295
13Fatty Acid Oxidation Disorders & Body Weight Regulation GrantCompletedNCT00654004
14Characterization of Obesity-related Cardiomyopathy Through Exploration of Human Atrial Trabeculae ContractionRecruitingNCT02384252
15Heart and Muscle Metabolism in Barth SyndromeRecruitingNCT01625663
16Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)RecruitingNCT02316314
17Fat and Sugar Metabolism During Exercise in Patients With Metabolic MyopathyRecruitingNCT02635269
18Fatty Acid Oxidation Defects and Insulin SensitivityRecruitingNCT02517307
19Inherited Retinal Degenerative Disease RegistryRecruitingNCT02435940
20The Genetics of Cardiomyopathy and Heart FailureActive, not recruitingNCT00703443
21Compassionate Use of Triheptanoin (C7) for Fatty Acid Oxidation Disorders and Glycogen Storage DiseaseAvailableNCT01461304
22Relationship Between Abnormalities of Desmin Cytoskeleton, Mitochondrial Activity and Expression of Ubiquitin in Aspect of Pathogenesis of Heart Failure and PrognosisNot yet recruitingNCT00819442
23Vitamin E Treatment for Long-Chain 3-Hydroxyacyl Coenzyme A (CoA) Dehydrogenase (LCHAD) Associated NeuropathyTerminatedNCT00840112

Search NIH Clinical Center for Mitochondrial Cardiomyopathy

Genetic Tests for Mitochondrial Cardiomyopathy

About this section

Genetic tests related to Mitochondrial Cardiomyopathy:

id Genetic test Affiliating Genes
1 Mitochondrial Cardiomyopathy22 MT-TL1

Anatomical Context for Mitochondrial Cardiomyopathy

About this section

MalaCards organs/tissues related to Mitochondrial Cardiomyopathy:

33
Heart, Skeletal muscle, Brain, Liver, T cells, Neutrophil, Endothelial

Animal Models for Mitochondrial Cardiomyopathy or affiliated genes

About this section

Publications for Mitochondrial Cardiomyopathy

About this section

Articles related to Mitochondrial Cardiomyopathy:

(show top 50)    (show all 61)
idTitleAuthorsYear
1
Cytotoxic activity of triazole-containing alkyl I^-D-glucopyranosides on a human T-cell leukemia cell line. (25705252)
2015
2
Molecular Genetic Mechanisms of Chronic Urticaria. (24404388)
2014
3
Social Skills and Executive Function Among Youth With Sickle Cell Disease: A Preliminary Investigation. (24431467)
2014
4
HLA-G polymorphism (rs16375) and acute rejection in liver transplant recipients. (24591768)
2014
5
A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice. (25227779)
2014
6
Prevalence of dentine hypersensitivity in Chinese rural adults with dental fluorosis. (24484047)
2014
7
Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis. (23612905)
2013
8
A safe technique for radical antegrade modular pancreatosplenectomy with venous resection for pancreatic cancer. (24045139)
2013
9
Use of tincture of opium compared to oral morphine for the treatment of neonatal abstinence syndrome. (23709305)
2013
10
IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function. (22454393)
2012
11
Genetic Loci implicated in erythroid differentiation and cell cycle regulation are associated with red blood cell traits. (22560525)
2012
12
Identification and antibiogram of microbes associated with bovine mastitis. (21774624)
2011
13
Effects of the association between the I+-subunit thigh and the I^-Subunit EGF2 domains on integrin activation and signaling. (21966982)
2011
14
FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy. (21941087)
2011
15
Characterization of the human tRNA-guanine transglycosylase: confirmation of the heterodimeric subunit structure. (20354154)
2010
16
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. (19177205)
2009
17
Thoracic outlet syndrome in a patient with Poland syndrome. (19766845)
2009
18
Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanisms. (18395088)
2008
19
Tectocerebellar dysraphia and occipital encephalocele: an unusual association with abdominal situs inversus and congenital heart disease. (18810345)
2008
20
Hyperglycosylated hCG. (17346790)
2007
21
Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. (17854302)
2007
22
In vivo and in vitro allergy diagnostics: it's time to re-appraise the costs. (17378739)
2007
23
No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes. (17532189)
2007
24
Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women. (17306638)
2007
25
Comments on: management of proliferative diabetic retinopathy. (18201512)
2007
26
Sequential triage in the first trimester may enhance advanced ultrasound scanning in population screening for trisomy 21. (16710884)
2006
27
Pegfilgrastim: a granulocyte colony-stimulating factor with sustained duration of action. (16318427)
2005
28
Signalling to the nucleus via A-kinase anchoring proteins. (15565886)
2004
29
Oxidative-stress-related proteome changes in Helicobacter pylori-infected human gastric mucosa. (14711373)
2004
30
Human septin-septin interactions as a prerequisite for targeting septin complexes in the cytosol. (15214843)
2004
31
Primary esophageal lymphoma: a diagnostic challenge in acquired immunodeficiency syndrome--two case reports and review. (15108833)
2004
32
Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. (15084244)
2004
33
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha. (12970782)
2003
34
Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin. (12235004)
2002
35
Differential gene expression profiling in human brain tumors. (11161003)
2001
36
Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas. (11453809)
2001
37
Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh. (10573132)
1999
38
Coccidioidomycosis. (9189666)
1997
39
Giant infiltrating lipoma of the thigh causing sciatica. (9137169)
1997
40
Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. (7565065)
1995
41
Chronic exposure to benzodiazepine receptor ligands uncouples the gamma-aminobutyric acid type A receptor in WSS-1 cells. (7808424)
1994
42
Mutations in acid beta-galactosidase cause GM1-gangliosidosis in American patients. (8213816)
1993
43
A novel mutation (Arg-->Leu in exon 18) in factor VIII gene responsible for moderate hemophilia A. (1301194)
1992
44
Vaginal leukocyte characteristics in urogenital trichomoniasis. (1586477)
1992
45
Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. (2123888)
1990
46
Autoimmunity and circulating immune complexes in retinal vasculitis. (6985101)
1981
47
Middle-ear carcinoma in a girl of eighteen. (7391668)
1980
48
Case report. Sturge Weber syndrome with cystic disease of lung and other congenital malformations. (721170)
1978
49
Congestive heart failure in neonatal thyrotoxicosis. A curable casue of heart failure in the newborn. (1192685)
1975
50
Effects of isolation on retrograde amnesia produced by ECS in multiple trial learning. (4856542)
1974

Variations for Mitochondrial Cardiomyopathy

About this section

Expression for genes affiliated with Mitochondrial Cardiomyopathy

About this section
Search GEO for disease gene expression data for Mitochondrial Cardiomyopathy.

Pathways for genes affiliated with Mitochondrial Cardiomyopathy

About this section

Pathways related to Mitochondrial Cardiomyopathy according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.2AARS, AARS2, MT-TL1

GO Terms for genes affiliated with Mitochondrial Cardiomyopathy

About this section

Biological processes related to Mitochondrial Cardiomyopathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1tRNA aminoacylation for protein translationGO:00064189.8AARS, AARS2
2tRNA aminoacylationGO:00430399.5AARS, AARS2
3tRNA modificationGO:00064009.4AARS, AARS2

Molecular functions related to Mitochondrial Cardiomyopathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1ligase activity, forming aminoacyl-tRNA and related compoundsGO:00168769.5AARS, AARS2

Sources for Mitochondrial Cardiomyopathy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet